Venous and arterial thromboembolic events after COVID-19 during the Omicron period in three European countries

X Xintong Li (Shanghai Key Laboratory of Green Chemistry and Chemical Processes, State Key Laboratory of Petroleum Molecular & Process Engineering, School of Chemistry and Molecular Engineering, East China Normal University, North Zhongshan Rd. 3663, Shanghai 200062, China) A Annika M. Jödicke A Albert Prats-Uribe A Antonella Delmestri K Katia Verhamme M Mees Mosseveld J James T. Brash D Dina Vojinovic A Anna Palomar-Cros L Laura Pérez Crespo T Talita Duarte-Salles M Marek Oja R Raivo Kolde E Edward Burn D Denise Umuhire D Daniel R. Morales M Martí Català

Abstract

Abstract Patients with earlier SARS-CoV-2 variants are at increased risk of venous and arterial thromboembolic (VTE, ATE) events. Here we aimed to contextualise the incidence of thromboembolic events among patients with COVID-19 during the Omicron period. We conducted a population-based cohort study using electronic health records from the UK (CPRD GOLD), the Netherlands (IPCI), and Spain (SIDIAP) within the DARWIN EU ® network. Two cohorts were included: a pre-pandemic population (2017–2019) and individuals infected with SARS-CoV-2 during the Omicron-dominant period. We estimated incidence rates (IRs) of VTE, ATE, and other cardiovascular events at 30-, 60-, 90-, and 180-days post-infection. Crude incidence rate ratios (IRRs) and age-sex standardized incidence ratios (SIRs) were calculated relative to the pre-pandemic cohort. Analyses were stratified by prior infection, vaccination status, and immunocompromised status. In total, we included over 7.6 million individuals (CPRD GOLD: 5.28 M; IPCI: 1.59 M; SIDIAP: 0.75 M) in the general population cohort, and about 0.8 million individuals (CPRD GOLD: 248,847; IPCI: 330,200; SIDIAP: 200,563) in the COVID-19 Omicron cohort. Crude IRs varied by outcome and data source. For VTE, IRs per 100,000 person-years were 136 [95%CI 131–141] in SIDIAP, 167 [164–169] in CPRD GOLD, and 264 [259–270] in IPCI. Elevated SIRs for VTE and ATE were observed following SARS-CoV-2 infection, highest within 30 days and persisting up to 180 days. In CPRD GOLD, the VTE SIR was 3.61 [2.45–5.53] at 30 days, decreasing to 1.88 [1.52–2.34] at 180 days. Higher SIRs were observed among immunocompromised individuals and those without prior infection. Our findings indicate that among individuals diagnosed with SARS-CoV-2 infection during the Omicron-dominant period, observed rates of thromboembolic events exceeded expected background incidence, particularly in the early post-infection period.

Article Details

Volume / Issue Vol. 16, Issue 1
Published May 15, 2026
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (17)

X

Xintong Li

Shanghai Key Laboratory of Green Chemistry and Chemical Processes, State Key Laboratory of Petroleum Molecular & Process Engineering, School of Chemistry and Molecular Engineering, East China Normal University, North Zhongshan Rd. 3663, Shanghai 200062, China

A

Annika M. Jödicke

A

Albert Prats-Uribe

A

Antonella Delmestri

K

Katia Verhamme

M

Mees Mosseveld

J

James T. Brash

D

Dina Vojinovic

A

Anna Palomar-Cros

L

Laura Pérez Crespo

T

Talita Duarte-Salles

M

Marek Oja

R

Raivo Kolde

E

Edward Burn

D

Denise Umuhire

D

Daniel R. Morales

M

Martí Català